CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Cash and cash equivalents
Total cash, and cash equivalents	$ 182,476	$ 41,574
Prepaid expenses	6,777	19,057
Other current assets	14,667	2,254
Total current assets	211,886	142,976
Property and equipment, net	24,404	22,659
Operating lease right-of-use assets	47,156	13,941
Restricted cash	14,062	13,496
Other assets	0	779
Total assets	297,508	193,851
Current liabilities:
Accounts payable	11,351	19,537
Accrued expenses and other current liabilities	15,904	14,110
Accrued settlement payment — related party	0	13,500
Deferred revenue — related party	7,092	0
Operating lease liability	3,614	9,276
Total current liabilities	37,961	56,423
Deferred revenue, net of current — related party	63,218	0
Operating lease liability, net of current	37,180	4,357
Research and development funding liability	6,000	0
Total liabilities	144,359	60,780
Commitments and contingencies (Note 12)
Stockholders’ equity
Common stock, par value of $0.00001 per share; 775,000,000 shares authorized; 131,160,842 and 97,377,121 shares issued and outstanding as of December 31, 2024 and 2023, respectively	2	2
Additional paid-in capital	840,358	624,414
Accumulated other comprehensive loss	1	(15)
Accumulated deficit	(687,212)	(491,330)
Total stockholders’ equity	153,149	133,071
Total liabilities and stockholders’ equity	297,508	193,851
Nonrelated Party
Cash and cash equivalents
Short-term investments	2,998	74,639
Related Party
Cash and cash equivalents
Short-term investments	$ 4,968	$ 5,452